Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily Lantus plus single Apidra injection vs twice-daily premixed insulin in type 2 diabetes
2009-015742-34Phase 4Completed
- Sponsor
- Sanofi
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Lantus + Apidra with NovoMix 30/70 (2 arms). Primary endpoint: HbA1c reduction. Started Nov 2009; status: completed.
02
Drugs
insulin glarginehuman insulinbiphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-015742-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015742-34.